Rights and permissions
About this article
Cite this article
Levocetirizine relieves costs related to PAR in France. Pharmacoecon. Outcomes News 478, 5 (2005). https://doi.org/10.2165/00151234-200504780-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504780-00010